Literature DB >> 14764530

Severe chronic graft-versus-host disease is characterized by a preponderance of CD4(+) effector memory cells relative to central memory cells.

Kouhei Yamashita1, Uimook Choi, Patricia C Woltz, Susan F Foster, Michael C Sneller, Francis T Hakim, Daniel H Fowler, Michael R Bishop, Steven Z Pavletic, Marisa Tamari, Kathleen Castro, A John Barrett, Richard W Childs, Gabor G Illei, Susan F Leitman, Harry L Malech, Mitchell E Horwitz.   

Abstract

Donor alloreactive CD4(+) T cells are important to the pathogenesis of chronic graft-versus-host disease (cGVHD), but specific subsets of CD4(+) T cells responsible for GVHD have not been defined. We hypothesized that cGVHD might be associated with a preponderance of CD4(+) effector memory cells (CCR7(-)/CD62L(low), CD4(EM)). We analyzed CCR7 and CD62L expression on CD4(+) T cells from stem cell transplantation patients, who did or did not develop cGVHD, and healthy donors. Patients with cGVHD had a higher percentage of CD4(EM) cells (35.5% +/- 2.9%) than healthy donors (13.8% +/- 0.7%; P <.0001) or patients without cGVHD that received a transplant (21.7% +/- 2.1%; P <.01). Using corticosteroid dose as a surrogate marker for cGVHD severity, severe cGVHD was associated with a higher percentage of CD4(EM) cells. The proportion of CD4(EM) cells in corticosteroid-dependent patients with systemic lupus erythematosis or Wegener granulomatosis did not differ from patients without cGVHD that received a transplant. This finding implies that overrepresentation of CD4(EM) cells is a unique feature of cGVHD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14764530     DOI: 10.1182/blood-2003-09-3286

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  29 in total

Review 1.  K+ channels as targets for specific immunomodulation.

Authors:  K George Chandy; Heike Wulff; Christine Beeton; Michael Pennington; George A Gutman; Michael D Cahalan
Journal:  Trends Pharmacol Sci       Date:  2004-05       Impact factor: 14.819

2.  IL-10+ regulatory B cells are enriched in cord blood and may protect against cGVHD after cord blood transplantation.

Authors:  Anushruti Sarvaria; Rafet Basar; Rohtesh S Mehta; Hila Shaim; Muharrem Muftuoglu; Ahmad Khoder; Takuye Sekine; Elif Gokdemir; Kayo Kondo; David Marin; May Daher; Amin M Alousi; Abdullah Alsuliman; Enli Liu; Betul Oran; Amanda Olson; Roy B Jones; Uday Popat; Chitra Hosing; Richard Champlin; Elizabeth J Shpall; Katayoun Rezvani
Journal:  Blood       Date:  2016-07-20       Impact factor: 22.113

3.  Kinetics of lymphocyte reconstitution after allogeneic bone marrow transplantation: markers of graft-versus-host disease.

Authors:  Severin Zinöcker; Lisbet Sviland; Ralf Dressel; Bent Rolstad
Journal:  J Leukoc Biol       Date:  2011-04-15       Impact factor: 4.962

4.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2014 Biomarker Working Group Report.

Authors:  Sophie Paczesny; Frances T Hakim; Joseph Pidala; Kenneth R Cooke; Julia Lathrop; Linda M Griffith; John Hansen; Madan Jagasia; David Miklos; Steven Pavletic; Robertson Parkman; Estelle Russek-Cohen; Mary E D Flowers; Stephanie Lee; Paul Martin; Georgia Vogelsang; Marc Walton; Kirk R Schultz
Journal:  Biol Blood Marrow Transplant       Date:  2015-01-30       Impact factor: 5.742

Review 5.  Oral graft-versus-host disease.

Authors:  M M Imanguli; I Alevizos; R Brown; S Z Pavletic; J C Atkinson
Journal:  Oral Dis       Date:  2008-07       Impact factor: 3.511

6.  Interleukin-10 spot-forming cells as a novel biomarker of chronic graft-versus-host disease.

Authors:  Masahiro Hirayama; Eiichi Azuma; Atsuko Nakagawa-Nakazawa; Tadashi Kumamoto; Shotaro Iwamoto; Keishiro Amano; Shigehisa Tamaki; Eiji Usui; Yoshihiro Komada
Journal:  Haematologica       Date:  2012-06-24       Impact factor: 9.941

7.  Preconditioning therapy with lentiviral vector-programmed dendritic cells accelerates the homeostatic expansion of antigen-reactive human T cells in NOD.Rag1-/-.IL-2rγc-/- mice.

Authors:  Gustavo Salguero; Bala Sai Sundarasetty; Sylvia Borchers; Dirk Wedekind; Britta Eiz-Vesper; Sarvari Velaga; Adan C Jirmo; Georg Behrens; Gregor Warnecke; Ann-Kathrin Knöfel; Rainer Blasczyk; Eva Mischak-Weissinger; Arnold Ganser; Renata Stripecke
Journal:  Hum Gene Ther       Date:  2011-07-27       Impact factor: 5.695

8.  Influence of T-cell depletion on chronic graft-versus-host disease: results of a multicenter randomized trial in unrelated marrow donor transplantation.

Authors:  Steven Z Pavletic; Shelly L Carter; Nancy A Kernan; Jean Henslee-Downey; Adam M Mendizabal; Esperanza Papadopoulos; Roger Gingrich; James Casper; Saul Yanovich; Daniel Weisdorf
Journal:  Blood       Date:  2005-07-26       Impact factor: 22.113

9.  Inhibition of histone methylation arrests ongoing graft-versus-host disease in mice by selectively inducing apoptosis of alloreactive effector T cells.

Authors:  Shan He; Jina Wang; Koji Kato; Fang Xie; Sooryanarayana Varambally; Shin Mineishi; Rork Kuick; Kazuhiro Mochizuki; Yongnian Liu; Evelyn Nieves; Ram-Shankar Mani; Arul M Chinnaiyan; Victor E Marquez; Yi Zhang
Journal:  Blood       Date:  2011-11-23       Impact factor: 22.113

10.  Imbalance of effector and regulatory CD4 T cells is associated with graft-versus-host disease after hematopoietic stem cell transplantation using a reduced intensity conditioning regimen and alemtuzumab.

Authors:  Katie Matthews; ZiYi Lim; Behdad Afzali; Laurence Pearce; Atiyeh Abdallah; Shahram Kordasti; Antonio Pagliuca; Giovanna Lombardi; J Alejandro Madrigal; Ghulam J Mufti; Linda D Barber
Journal:  Haematologica       Date:  2009-06-02       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.